News

In October, 7 new users have joined the Latvian medicines verification system (LZVS), thus a total of 1257 system end users have joined the system in Latvia and the safety of medicines can be verified by them.

Attesting their qualification and high operating standards of the LZVO, more and more specialists of the Latvian Medicines Verification Organisation (LZVO) hold positions at the international level.

EMVO has been working to manage the implications of Brexit (the UK’s departure from the EU Internal Market rules) for the EMVS and its users.

Latvian Medicines Verification Organization (LZVO) will work in a mixed mode from 9 November to 6 December

Updates to the Latvian Medicines Verification System (LMVS) prepared by the system developer Arvato Systems GmbH have been successfully installed and operational since 20 October.

Starting from October, a Quality Council was established in the Arvato group that includes 16 countries and a representative of the Latvian Medicines Verification Organization (LZVO) was elected in the Council.